The Asia Pacific newborn screening market is expected to grow rapidly in the coming years due to various factors, such as increasing awareness about the benefits of early detection of genetic disorders and metabolic diseases, rising prevalence of these disorders, and increasing government initiatives to improve healthcare infrastructure. Additionally, the growing focus of key market players on expanding their presence in the region through strategic collaborations, partnerships, and acquisitions is also expected to fuel market growth. However, the high cost of screening tests and inadequate healthcare facilities in certain countries may hinder market growth. Overall, the Asia Pacific newborn screening market is poised for significant growth in the coming years, driven by increasing demand for early detection and treatment of genetic disorders and metabolic diseases in infants.
The Asia Pacific Newborn Screening Market is estimated to be valued at US$ 308.9 million in 2022 and is expected to exhibit a CAGR of 12.9% during the forecast period (2022-2030).
Prominent Companies in the Asia Pacific Newborn Screening Industry:
1. Medtronic plc: Medtronic plc is a multinational medical technology company that was founded in 1949. The company is headquartered in Dublin, Ireland, and operates in over 160 countries worldwide. Medtronic offers a range of products and services in the healthcare sector, including devices for newborn screening. In 2021, Medtronic announced the launch of a new product called the Early Access Program for Congenital Hypothyroidism, which is designed to improve the early detection of the condition in newborns.
2. Agilent Technologies: Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2020, Agilent announced the launch of the Agilent SureScan Dx Microarray Scanner, which is designed to improve the accuracy and efficiency of newborn screening tests.
3. Waters Technologies Corporation: Waters Technologies Corporation is a global leader in analytical science technologies. The company was founded in 1958 and is headquartered in Milford, Massachusetts. Waters offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2021, Waters announced the launch of a new product called the MassTrak Neonatal Kit, which is designed to improve the accuracy and speed of newborn screening tests.
4. AB SCIEX: AB SCIEX is a global leader in life science research and analytical technologies. The company was founded in 1970 and is headquartered in Framingham, Massachusetts. AB SCIEX offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2020, AB SCIEX announced the launch of a new product called the Triple Quad 6500+ LC-MS/MS System, which is designed to improve the sensitivity and speed of newborn screening tests.
5. Bio-Rad Laboratories: Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics. The company was founded in 1952 and is headquartered in Hercules, California. Bio-Rad offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2021, Bio-Rad announced the launch of a new product called the Neonatal Bilirubin Total Assay, which is designed to improve the accuracy and efficiency of newborn screening tests.
6. Covidien PLC: Covidien PLC is a global leader in medical devices and supplies. The company was founded in 2007 and is headquartered in Dublin, Ireland. Covidien offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2020, Covidien announced the launch of a new product called the Nellcor Bedside SpO2 Patient Monitoring System, which is designed to improve the accuracy and efficiency of newborn screening tests.
7. GE Life Sciences: GE Life Sciences is a global leader in healthcare and biotechnology. The company was founded in 2004 and is headquartered in Marlborough, Massachusetts. GE Life Sciences offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2020, GE Life Sciences launched a new platform called the Biacore 8K, which is designed to help researchers develop and optimize the production of therapeutic antibodies.
8. Masimo Corporation is a medical technology company headquartered in Irvine, California, United States. It was founded in 1989 and offers a range of solutions for monitoring and screening newborns, including pulse oximeters and non-invasive hemoglobin monitoring. Masimo Corporation operates in more than 100 countries and announced in 2021 that its Masimo SafetyNet solution had been selected for use in the United Kingdom's National Health Service (NHS) COVID-19 Home Monitoring program.
9. Natus Medical Inc. was founded in 1987 and is headquartered in Pleasanton, California, United States. The company offers a range of products and services for newborn screening, including hearing screening and diagnostic testing for genetic disorders. Natus Medical Inc. operates in more than 30 countries and announced in 2020 that it had received approval from the US Food and Drug Administration (FDA) for its ALGO 5 Newborn Hearing Screener.
10. PerkinElmer Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts, United States. The company offers a range of solutions for newborn screening, including diagnostics for genetic disorders and metabolic diseases. PerkinElmer Inc. operates in more than 150 countries and announced in 2020 that it had received approval from the US FDA for its GSP Neonatal Creatine Kinase-MM kit, which is used to detect a rare genetic disorder called Duchenne muscular dystrophy.
11. Trivitron Healthcare Pvt. Ltd. was founded in 1997 and is headquartered in Chennai, India. The company offers a range of products and services for newborn screening, including diagnostic testing for genetic disorders and metabolic diseases. Trivitron Healthcare Pvt. Ltd. operates in more than 180 countries and announced in 2021 that it had acquired a stake in Biosense Technologies Pvt. Ltd., a company that develops medical devices for the diagnosis of infectious diseases.
12. ZenTech S.A. was founded in 1997 and is headquartered in Liège, Belgium. The company offers a range of products and services for newborn screening, including diagnostics for genetic disorders and metabolic diseases. ZenTech S.A. operates in more than 50 countries and announced in 2020 that it had received approval from the European Union for its COVID-19 antibody test.
*Definition- Newborn screening is a process of testing infants shortly after birth for genetic and metabolic disorders that may not be apparent at birth but can lead to serious health problems if not detected and treated early.
